YVELINE JACQUES: Open Payments
NPI 1356891915 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,742 in 93 payments from 14 companies in 2025. Trend: 2023 $1,304 · 2024 $1,892 · 2025 $2,742
Food & beverage: $2,742
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $504 |
| ABBVIE INC. | 17 | $446 |
| Teva Pharmaceuticals USA, Inc. | 8 | $334 |
| Vanda Pharmaceuticals Inc. | 9 | $297 |
| Axsome Therapeutics, Inc. | 6 | $250 |
| Alkermes, Inc. | 8 | $190 |
| Janssen Pharmaceuticals, Inc | 6 | $162 |
| Otsuka America Pharmaceutical, Inc. | 7 | $156 |
| E.R. Squibb & Sons, L.L.C. | 5 | $130 |
| Neurocrine BioSciences, Inc. | 3 | $94 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, Auvelity, FANAPT, REXULTI, COBENFY, HETLIOZ.
Industry payments across FL — which companies pay providers there.
